Literature DB >> 28597104

[Upper abdominal pain, nausea, and vomiting in a 63-year-old woman].

S Schwarzer1, K Rapis2.   

Abstract

We present a case of myotonic dystrophy type I and its complications including cholangitis and cardiac arrhythmias. The therapy options focus on the consequences of the disease and result in an endoscopic retrograde cholangiography (ERC) and implantation of an implantable cardioverter-defibrillator (ICD). Myotonic dystrophy is a disease which results in a loss of smooth and skeletal muscle cells leading to multiple consequences such as gastrointestinal symptoms and cardiac manifestations.

Entities:  

Keywords:  Atrioventricular block; Cholangitis; Cholestasis; Myotonic dystrophy; Tachycardia, ventricular

Mesh:

Year:  2017        PMID: 28597104     DOI: 10.1007/s00108-017-0271-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  12 in total

1.  99th ENMC international workshop: myotonic dystrophy: present management, future therapy. 9-11 November 2001, Naarden, The Netherlands.

Authors:  P S Harper; B G M van Engelen; B Eymard; M Rogers; D Wilcox
Journal:  Neuromuscul Disord       Date:  2002-08       Impact factor: 4.296

2.  Sump syndrome as a complication of choledochoduodenostomy.

Authors:  Motaz Qadan; Sharon Clarke; Ellen Morrow; George Triadafilopoulos; Brendan Visser
Journal:  Dig Dis Sci       Date:  2011-12-14       Impact factor: 3.199

3.  Anicteric cholestasis: an unusual presentation of myotonic dystrophy.

Authors:  W-K Syn; A A Palejwala
Journal:  Intern Med J       Date:  2009-03       Impact factor: 2.048

Review 4.  Mechanisms and management of the heart in myotonic dystrophy.

Authors:  Elizabeth M McNally; Dina Sparano
Journal:  Heart       Date:  2011-07       Impact factor: 5.994

Review 5.  Cardiac manifestations of myotonic dystrophy type 1.

Authors:  Helle Petri; John Vissing; Nanna Witting; Henning Bundgaard; Lars Køber
Journal:  Int J Cardiol       Date:  2011-09-13       Impact factor: 4.164

6.  Two infantile cases of congenital myotonic dystrophy with cholelithiasis/cholestasis.

Authors:  Muneichiro Sumi; Takashi Kusumoto; Masato Tagawa; Tatsuro Kondoh; Yasuharu Ohno; Hideaki Masuzaki; Tadayuki Ishimaru; Hiroyuki Moriuchi
Journal:  Pediatr Int       Date:  2005-10       Impact factor: 1.524

Review 7.  Myotonic dystrophy and the heart: A systematic review of evaluation and management.

Authors:  J K Lau; R W Sy; A Corbett; L Kritharides
Journal:  Int J Cardiol       Date:  2015-03-05       Impact factor: 4.164

8.  Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.

Authors:  William J Groh; Miriam R Groh; Chandan Saha; John C Kincaid; Zachary Simmons; Emma Ciafaloni; Rahman Pourmand; Richard F Otten; Deepak Bhakta; Girish V Nair; Mohammad M Marashdeh; Douglas P Zipes; Robert M Pascuzzi
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

9.  [Incidence of disposition for malignant hyperthermia in patients with neuromuscular diseases].

Authors:  F Wappler; J Scholz; V von Richthofen; M Fiege; A Köchling; J Matschke; G Winkler; J Schulte am Esch
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  1998-06       Impact factor: 0.698

10.  Abnormal liver test results in myotonic dystrophy.

Authors:  A Achiron; Y Barak; N Magal; M Shohat; M Cohen; R Barar; N Gadoth
Journal:  J Clin Gastroenterol       Date:  1998-06       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.